This job has expired

You will need to login before you can apply for a job.

Sr. Manager, Business Development - Strategic Mapping

BioMarin Pharmaceutical Inc.
San Rafael, California
Start date
Sep 13, 2023

Job Details

Who We Are

It takes a village, and at BioMarin our corporate groups are the people behind our success. Groups such as IT, Finance, Legal, Global Compliance & Ethics, and our People Team provide foundational support of all areas of operation at BioMarin.

The Business and Corporate Development function plays a critical role in the strategic growth of BioMarin by leading corporate strategy initiatives and executing various types of transactions (e.g., licensing, M&A, partnership efforts) to shape our pipeline.

Please note we can consider candidates at the Manager or Sr. Manager Level.
Location is San Rafael, two days on-site, three days work from home.
We can also consider Remote US candidates.


This role will report to George Ye, Executive Director of Business and Corporate Development.

The new hire will initially be focused on creating strategic, actionable, asset-centric landscapes across different areas of interest, and may grow into other BD and Alliance Management roles such as deal lead, transaction lead, and alliance manager to advance BioMarin’s rare and genetic disease product pipeline. This high-impact role will be critical in providing strategic analysis and guidance for driving BioMarin’s inorganic growth lever.

The new hire will work closely with BD deal leads to identify therapeutic areas and indications of high interest for buy-side projects. The specific focus of this individual will be on targeted medicines for genetic rare diseases, developing sophisticated, detailed landscapes across different indications to identify assets of interest and areas of white space. In addition, this person will work with other teammates to create and formalize this process with the goal of curating and maintaining existing landscapes efficiently and sustainably. This person must have an exceptional ability to rapidly learn and digest large amounts of information and then organize and synthesize the learnings in written and verbal presentations for internal strategic discussions.  This person may also support other initiatives (e.g., buy-side, sell-side, and corporate strategy) that support the corporate vision and goals.


Responsibilities may include, but are not limited to:

  • Secondary / primary research for landscape analysis (e.g., indications of specific interest)
  • Secondary / primary research for asset evaluation (e.g., scientific publications, analyst reports, Key Opinion Leader interviews)
  • Monitoring of new academic publications and industry news
  • Research and document creation for the team as part of evaluation (e.g., PowerPoints for assets under evaluation)
  • Creating and optimizing the process for landscape analysis
  • Develop into internal SMEs by understanding the disease biology, influential KOLs, treatment paradigm, and new and emerging therapeutics for relevant landscapes



  • Must have MD/PhD with “VC mindset”
  • Excellent verbal and written communication skills
  • Able to collect and synthesize a wide range of scientific and clinical information
  • Organized and capable of multi-tasking. Strong attention to detail.
  • Scientifically strategic with an ownership mindset. Ability to produce quality deliverables and motivated to work with tight deadlines
  • Excels at working collaboratively with others
  • Excellent analytical and organizational skills with the ability to make sound business judgments
  • Passionate about learning about business development in a fast-paced environment
  • Experience in BD in small to mid-size Biotech companies preferred
  • Robust understanding of the full drug development process, life-cycle management and commercialization of therapeutics (rare disease preferred)
  • Strong EQ combined with scientific/technical acumen of the clinical development process
  • A strategic thinker with outstanding business instincts who can help chart the course and translate into actionable, value-creating results for the company
  • Energetic, resourceful self-starter with high integrity, strong executive presence, and the ability to work effectively in a dynamic, entrepreneurial environment that requires "win-win" collaboration at all levels
  • Top-Tier Venture Capital experience is a +



We are an equal opportunity employer and all qualified applicants will receive consideration for employment without regard to race, color, religion, gender, gender identity, sexual orientation, national origin, disability status, protected veteran status, or any other characteristic protected by law.


BioMarin is a global biotechnology company dedicated to transforming lives through genetic discovery. In 1997, the company was founded to make a big difference in small patient populations, focusing on giving much-needed attention to the underserved communities of those with rare diseases. BioMarin sought to help patients whose voices could not always be heard and treat conditions that were not always in mainstream medical conversations. Throughout its history, BioMarin has worked tirelessly to make a difference by pursuing bold science. The company’s first approved therapy was inspired by a father who refused to accept there was no therapy for his son’s rare diagnosis. That relentless pursuit to change the course of his son’s future through the power of science is at the core of who BioMarin is today.

Through the company’s expertise in genetics and molecular biology, BioMarin has developed eight first or best-in-class targeted therapies that address the root cause of the conditions it seeks to treat, helping to better the lives of those struggling with rare genetic disease. The company’s purposeful and scientifically precise team of physicians and scientists has honed each treatment modality to seek transformative therapies.

Now, BioMarin seeks to make an even greater impact by applying the same science-driven, patient-forward approach that propelled the last 25 plus years of drug development to larger genetic disorders, as well as genetic subsets of more common conditions. Each drug candidate pursued is guided by a fundamental understanding of the genetics and underlying biology of the condition it will address. The company believes that applying its knowledge to make a transformative impact is not just a calling, but an obligation to those who will benefit most. The more innovative solutions developed, the more lives BioMarin can impact.

Company info
United States

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert